Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Seres Therapeutics, Inc. (MCRB) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/17/2018 BW Seres Therapeutics to Host Microbiome R&D Event and Webcast on May 24, 2018
05/09/2018 BW Seres Therapeutics Reports First Quarter Financial Results and Provides Operational Updates
03/08/2018 BW Seres Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates
03/02/2018 BW Seres Therapeutics to Host Fourth Quarter 2017 Financial Results and Operational Progress Conference Call and Webcast on March 8, 2018
11/08/2017 BW Seres Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on Operational Progress
11/02/2017 BW Seres Therapeutics to Host Third Quarter 2017 Financial Results and Operational Progress Conference Call and Webcast on November 8, 2017
10/02/2017 BW Seres Therapeutics Reports Positive Topline Results from SER-287 Phase 1b Study in Patients with Ulcerative Colitis
08/31/2017 BW Seres Therapeutics to Present at the Baird 2017 Global Healthcare Conference
08/03/2017 BW Seres Therapeutics Reports Second Quarter 2017 Financial Results and Provides Update on Operational Progress
07/27/2017 BW Seres Therapeutics to Host Second Quarter 2017 Financial Results and Operational Progress Conference Call and Webcast on August 3, 2017
05/04/2017 BW Seres Therapeutics Reports First Quarter 2017 Financial Results and Provides Update on Operational Progress
04/28/2017 BW Seres Therapeutics to Host First Quarter 2017 Financial Results and Operational Progress Conference Call and Webcast on May 4, 2017
03/16/2017 BW Seres Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Operational Progress Update
03/16/2017 BW Seres Therapeutics to Initiate New SER-109 Clinical Study
03/13/2017 BW Seres Therapeutics to Host Fourth Quarter 2016 Financial Results and Operational Progress Conference Call and Webcast on March 16, 2017
01/31/2017 BW Seres Therapeutics Announces Key Findings from SER-109 Phase 2 Study Analyses

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy